Aurobindo Pharma Ltd.

Aurobindo Pharma Ltd. is a prominent pharmaceutical company engaged in manufacturing and marketing a vast array of medicinal products across global markets. Established in 1986 and headquartered in Hyderabad, India, the company focuses on developing generic pharmaceutical formulations and active pharmaceutical ingredients (APIs). Aurobindo’s portfolio encompasses a wide range of therapeutic segments, including anti-infectives, neuroscience, cardiovascular products, and antiretrovirals, among others. The company supplies to over 150 countries, serving public health sectors, hospitals, and individual consumers. Aurobindo Pharma stands as a significant player in the pharmaceutical industry due to its extensive manufacturing capabilities and vertical integration from APIs to finished dosages. The company has achieved notable market presence through strategic acquisitions and a robust pipeline of over 600 formulations, making it one of the largest pharmaceutical exporters out of India. It continually invests in research and development to expand its product offerings and maintain compliance with international regulatory standards. Known for its cost-effective yet high-quality medication, Aurobindo plays a vital role in advancing accessibility to essential drugs in both developed and developing nations.